Literature DB >> 16545161

The influence of Helicobacter pylori infection and corpus gastritis on the postoperative outcomes of laparoscopic vertical banded gastroplasty.

Hsih-Hsi Wang1, Wei-Jei Lee, Phui-Ly Liew, Chang-Shyue Yang, Ren-Jow Liang, Weu Wang, Jaw-Town Lin, Ming-Shiang Wu.   

Abstract

BACKGROUND: Helicobacter pylori (HP) infection is linked to weight control through gastric inflammation-induced deregulation of satiety-related hormone, and eradication of HP before a weight reduction operation has been advocated. We aimed to examine the impact of HP infection and corpus gastritis on preoperative patient characteristics, postoperative complications and weight loss following laparoscopic vertical banded gastroplasty (LVBG).
METHODS: A prospective cohort of 152 patients undergoing LVBG was enrolled. Gastric specimens at the corpus were obtained during LVBG operation and scored histologically according to the Sydney classification of gastritis. Excess weight loss, and early and late complications following LVBG, were recorded and correlated.
RESULTS: 63 and 89 patients were identified as HP positive and negative groups respectively. The prevalence of individual components of the metabolic syndrome was comparable in both groups except hypertension. The occurrence of early and late complications, either minor or major, in both groups was similar. The severity of gastritis was correlated positively with age and negatively with preoperative BMI and excess weight. Patients with higher neutrophil activity, chronic inflammation, and HP density experienced less excess weight loss at 24 to 48 months follow-up. The impact of gastritis on weight loss became less recognizable after 48 months follow-up.
CONCLUSIONS: HP infection and gastric inflammation play a significant role in the amount of weight loss after LVBG. Further prospective studies should examine possible mechanisms and long-term effects on weight loss to determine the utility of preventive eradication of HP in different types of bariatric surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16545161     DOI: 10.1381/096089206776116417

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  7 in total

1.  Prevalence of Helicobacter pylori infection in a group of morbidly obese Saudi patients undergoing bariatric surgery: a preliminary report.

Authors:  Ahmad M Al-Akwaa
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

Review 2.  Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery.

Authors:  Marilia Carabotti; Chiara D'Ercole; Angelo Iossa; Enrico Corazziari; Gianfranco Silecchia; Carola Severi
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

3.  Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding.

Authors:  Hsin-Hung Chen; Wei-Jei Lee; Weu Wang; Ming-Te Huang; Yi-Chih Lee; Wen-Harn Pan
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

4.  The eradication of Helicobacter pylori is affected by body mass index (BMI).

Authors:  Mohamed Abdullahi; Bruno Annibale; Danila Capoccia; Roberto Tari; Edith Lahner; John Osborn; Frida Leonetti; Carola Severi
Journal:  Obes Surg       Date:  2008-04-29       Impact factor: 4.129

Review 5.  The Effect of Helicobacter pylori on Postoperative Outcomes in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Valentin Mocanu; Jerry T Dang; Noah Switzer; Daniel Skubleny; Xinzhe Shi; Chris de Gara; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

Review 6.  Helicobacter pylori infection and circulating ghrelin levels - a systematic review.

Authors:  Chidi V Nweneka; Andrew M Prentice
Journal:  BMC Gastroenterol       Date:  2011-01-26       Impact factor: 3.067

7.  GASTRIC AND JEJUNAL HISTOPATHOLOGICAL CHANGES IN PATIENTS UNDERGOING BARIATRIC SURGERY.

Authors:  Rosemary Simões Nomelini Rodrigues; Élia Cláudia de Souza Almeida; Silvia Maria Perrone Camilo; Júverson Alves Terra-Júnior; Lucinda Calheiros Guimarães; Ana Cristina da Rocha Duque; Renata Margarida Etchebehere
Journal:  Arq Bras Cir Dig       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.